• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Sphingosine-1-Phosphate Receptor 2 抑制剂 JTE013 通过促进血管生成增强肺泡骨再生。

Inhibition of Sphingosine-1-Phosphate Receptor 2 by JTE013 Enhanced Alveolar Bone Regeneration by Promoting Angiogenesis.

机构信息

Department of Oral Health Sciences, College of Dental Medicine, Medical University of South Carolina, Charleston, SC 29425, USA.

Division of Laboratory Animal Resources, Medical University of South Carolina, Charleston, SC 29425, USA.

出版信息

Int J Mol Sci. 2023 Feb 8;24(4):3401. doi: 10.3390/ijms24043401.

DOI:10.3390/ijms24043401
PMID:36834810
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9967474/
Abstract

Sphingosine-1-phosphate receptor 2 () is a G protein-coupled receptor that regulates various immune responses. Herein, we report the effects of a antagonist (JTE013) on bone regeneration. Murine bone marrow stromal cells (BMSCs) were treated with dimethylsulfoxide (DMSO) or JTE013 with or without infection by an oral bacterial pathogen . Treatment with JTE013 enhanced vascular endothelial growth factor A (), platelet derived growth factor subunit A (), and growth differentiation factor 15 () gene expression and increased transforming growth factor beta (TGFβ)/Smad and Akt signaling. Eight-week-old male C57BL/6J mice were challenged with ligatures around the left maxillary 2nd molar for 15 days to induce inflammatory bone loss. After ligature removal, mice were treated with diluted DMSO or JTE013 in the periodontal tissues 3 times per week for 3 weeks. Calcein was also injected twice to measure bone regeneration. Micro-CT scanning of maxillary bone tissues and calcein imaging revealed that treatment with JTE013 enhanced alveolar bone regeneration. JTE013 also increased , , osteocalcin, and osterix gene expressions in the periodontal tissues compared to control. Histological examination of periodontal tissues revealed that JTE013 promoted angiogenesis in the periodontal tissues compared to control. Our findings support that inhibition of by JTE013 increased TGFβ/Smad and Akt signaling; enhanced , , and gene expression; and subsequently promoted angiogenesis and alveolar bone regeneration.

摘要

鞘氨醇-1-磷酸受体 2() 是一种 G 蛋白偶联受体,可调节各种免疫反应。在此,我们报告了一种 拮抗剂 (JTE013) 对骨再生的影响。用二甲亚砜 (DMSO) 或 JTE013 处理骨髓基质细胞 (BMSCs),并在有或没有口腔细菌病原体感染的情况下进行处理。JTE013 处理增强了血管内皮生长因子 A()、血小板衍生生长因子亚基 A() 和生长分化因子 15() 的基因表达,并增加了转化生长因子β(TGFβ)/Smad 和 Akt 信号。将 8 周龄雄性 C57BL/6J 小鼠用结扎丝结扎左侧上颌第 2 磨牙 15 天,以诱导炎症性骨丧失。结扎去除后,将小鼠牙周组织每周用稀释的 DMSO 或 JTE013 处理 3 次,持续 3 周。还两次注射 calcein 以测量骨再生。上颌骨组织的 micro-CT 扫描和 calcein 成像显示,与对照相比,JTE013 处理增强了牙槽骨再生。与对照相比,JTE013 还增加了牙周组织中的、、骨钙素和骨形成蛋白-2 基因表达。牙周组织的组织学检查显示,与对照相比,JTE013 促进了牙周组织中的血管生成。我们的研究结果表明,JTE013 通过抑制 增加了 TGFβ/Smad 和 Akt 信号;增强了、和基因表达;并随后促进了血管生成和牙槽骨再生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3600/9967474/8b7f38c15571/ijms-24-03401-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3600/9967474/64fa0f4f95b7/ijms-24-03401-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3600/9967474/10e35912f785/ijms-24-03401-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3600/9967474/b0fccd8fc675/ijms-24-03401-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3600/9967474/49cb6d33a03e/ijms-24-03401-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3600/9967474/73216a893b7e/ijms-24-03401-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3600/9967474/8b7f38c15571/ijms-24-03401-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3600/9967474/64fa0f4f95b7/ijms-24-03401-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3600/9967474/10e35912f785/ijms-24-03401-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3600/9967474/b0fccd8fc675/ijms-24-03401-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3600/9967474/49cb6d33a03e/ijms-24-03401-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3600/9967474/73216a893b7e/ijms-24-03401-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3600/9967474/8b7f38c15571/ijms-24-03401-g006.jpg

相似文献

1
Inhibition of Sphingosine-1-Phosphate Receptor 2 by JTE013 Enhanced Alveolar Bone Regeneration by Promoting Angiogenesis.Sphingosine-1-Phosphate Receptor 2 抑制剂 JTE013 通过促进血管生成增强肺泡骨再生。
Int J Mol Sci. 2023 Feb 8;24(4):3401. doi: 10.3390/ijms24043401.
2
Inhibition of Sphingosine-1-Phosphate Receptor 2 by JTE013 Promoted Osteogenesis by Increasing Vesicle Trafficking, Wnt/Ca, and BMP/Smad Signaling.JTE013 通过增加囊泡转运、Wnt/Ca 和 BMP/Smad 信号来抑制鞘氨醇-1-磷酸受体 2,从而促进成骨作用。
Int J Mol Sci. 2021 Nov 8;22(21):12060. doi: 10.3390/ijms222112060.
3
Inhibition of sphingosine-1-phosphate receptor 2 attenuated ligature-induced periodontitis in mice.抑制鞘氨醇-1-磷酸受体 2 可减轻小鼠结扎诱导的牙周炎。
Oral Dis. 2021 Jul;27(5):1283-1291. doi: 10.1111/odi.13645. Epub 2020 Oct 8.
4
Sphingosine-1-Phosphate Receptor 2 Controls Podosome Components Induced by RANKL Affecting Osteoclastogenesis and Bone Resorption.鞘氨醇-1-磷酸受体 2 控制 RANKL 诱导的破骨细胞生成和骨吸收的破骨细胞足突相关成分。
Cells. 2019 Jan 1;8(1):17. doi: 10.3390/cells8010017.
5
Periodontal inflammation and alveolar bone loss induced by Aggregatibacter actinomycetemcomitans is attenuated in sphingosine kinase 1-deficient mice.牙龈卟啉单胞菌引起的牙周炎和牙槽骨丧失在鞘氨醇激酶 1 缺陷小鼠中减轻。
J Periodontal Res. 2016 Feb;51(1):38-49. doi: 10.1111/jre.12276. Epub 2015 Apr 20.
6
Targeting S1PRs as a Therapeutic Strategy for Inflammatory Bone Loss Diseases-Beyond Regulating S1P Signaling.针对 S1PR 作为炎症性骨丢失疾病的治疗策略——超越调节 S1P 信号。
Int J Mol Sci. 2021 Apr 23;22(9):4411. doi: 10.3390/ijms22094411.
7
Effects of S1PR2 antagonist on blood pressure and angiogenesis imbalance in preeclampsia rats.S1PR2拮抗剂对先兆子痫大鼠血压及血管生成失衡的影响。
Mol Med Rep. 2021 Jun;23(6). doi: 10.3892/mmr.2021.12095. Epub 2021 Apr 21.
8
Endothelial S1pr2 regulates post-ischemic angiogenesis via AKT/eNOS signaling pathway.内皮细胞 S1pr2 通过 AKT/eNOS 信号通路调节缺血后血管生成。
Theranostics. 2022 Jul 4;12(11):5172-5188. doi: 10.7150/thno.71585. eCollection 2022.
9
S1PR2 antagonist alleviates oxidative stress-enhanced brain endothelial permeability by attenuating p38 and Erk1/2-dependent cPLA phosphorylation.S1PR2 拮抗剂通过减弱 p38 和 Erk1/2 依赖的 cPLA 磷酸化来减轻氧化应激增强的脑内皮通透性。
Cell Signal. 2019 Jan;53:151-161. doi: 10.1016/j.cellsig.2018.09.019. Epub 2018 Oct 2.
10
[Effect of molar ligation and local Porphyromonas gingivalis inoculation on alveolar bone loss in the mouse].[磨牙结扎与局部接种牙龈卟啉单胞菌对小鼠牙槽骨吸收的影响]
Beijing Da Xue Xue Bao Yi Xue Ban. 2017 Feb 18;49(1):31-5.

引用本文的文献

1
Reversal of cholestatic liver disease by the inhibition of sphingosine 1-phosphate receptor 2 signaling.通过抑制鞘氨醇 1-磷酸受体 2 信号转导逆转胆汁淤积性肝病。
PeerJ. 2024 Jan 16;12:e16744. doi: 10.7717/peerj.16744. eCollection 2024.
2
The role of sphingosine-1-phosphate in the development and progression of Parkinson's disease.鞘氨醇-1-磷酸在帕金森病发生发展中的作用
Front Cell Neurosci. 2023 Dec 21;17:1288437. doi: 10.3389/fncel.2023.1288437. eCollection 2023.
3
The relationship between sphingosine-1-phosphate receptor 2 and epidermal growth factor in migration and invasion of oral squamous cell carcinoma.

本文引用的文献

1
Inhibition of Sphingosine-1-Phosphate Receptor 2 by JTE013 Promoted Osteogenesis by Increasing Vesicle Trafficking, Wnt/Ca, and BMP/Smad Signaling.JTE013 通过增加囊泡转运、Wnt/Ca 和 BMP/Smad 信号来抑制鞘氨醇-1-磷酸受体 2,从而促进成骨作用。
Int J Mol Sci. 2021 Nov 8;22(21):12060. doi: 10.3390/ijms222112060.
2
Resolution of inflammation in bone regeneration: From understandings to therapeutic applications.炎症在骨再生中的消退:从认识到治疗应用。
Biomaterials. 2021 Oct;277:121114. doi: 10.1016/j.biomaterials.2021.121114. Epub 2021 Sep 1.
3
GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease.
鞘氨醇-1-磷酸受体2与表皮生长因子在口腔鳞状细胞癌迁移和侵袭中的关系
Cancer Cell Int. 2023 Apr 10;23(1):65. doi: 10.1186/s12935-023-02906-w.
生长分化因子15:肥胖和心血管代谢疾病的新兴生物学及治疗应用
Nat Rev Endocrinol. 2021 Oct;17(10):592-607. doi: 10.1038/s41574-021-00529-7. Epub 2021 Aug 11.
4
Effects of S1PR2 antagonist on blood pressure and angiogenesis imbalance in preeclampsia rats.S1PR2拮抗剂对先兆子痫大鼠血压及血管生成失衡的影响。
Mol Med Rep. 2021 Jun;23(6). doi: 10.3892/mmr.2021.12095. Epub 2021 Apr 21.
5
Inhibition of sphingosine-1-phosphate receptor 2 attenuated ligature-induced periodontitis in mice.抑制鞘氨醇-1-磷酸受体 2 可减轻小鼠结扎诱导的牙周炎。
Oral Dis. 2021 Jul;27(5):1283-1291. doi: 10.1111/odi.13645. Epub 2020 Oct 8.
6
Growth differentiation factor 15: A novel biomarker with high clinical potential.生长分化因子 15:一种具有高临床应用潜力的新型生物标志物。
Crit Rev Clin Lab Sci. 2019 Aug;56(5):333-350. doi: 10.1080/10408363.2019.1615034. Epub 2019 May 27.
7
Sphingosine-1-Phosphate Receptor 2 Controls Podosome Components Induced by RANKL Affecting Osteoclastogenesis and Bone Resorption.鞘氨醇-1-磷酸受体 2 控制 RANKL 诱导的破骨细胞生成和骨吸收的破骨细胞足突相关成分。
Cells. 2019 Jan 1;8(1):17. doi: 10.3390/cells8010017.
8
PI3k/AKT signaling pathway: Erythropoiesis and beyond.PI3k/AKT 信号通路:红细胞生成及其他。
J Cell Physiol. 2019 Mar;234(3):2373-2385. doi: 10.1002/jcp.27262. Epub 2018 Sep 7.
9
Deoxycholic Acid-Mediated Sphingosine-1-Phosphate Receptor 2 Signaling Exacerbates DSS-Induced Colitis through Promoting Cathepsin B Release.去氧胆酸介导的鞘氨醇-1-磷酸受体 2 信号通过促进组织蛋白酶 B 释放加重 DSS 诱导的结肠炎。
J Immunol Res. 2018 May 9;2018:2481418. doi: 10.1155/2018/2481418. eCollection 2018.
10
Growth differentiation factor 15 promotes blood vessel growth by stimulating cell cycle progression in repair of critical-sized calvarial defect.生长分化因子 15 通过刺激细胞周期进程促进血管生长,从而修复临界尺寸的颅骨缺损。
Sci Rep. 2017 Aug 22;7(1):9027. doi: 10.1038/s41598-017-09210-4.